Navigating Growth in Age-related Vision Dysfunction Market The Age-related Vision Dysfunction Market is witnessing accelerated business growth as demographic shifts and technological advances reshape treatment paradigms. Rising prevalence of cataracts and macular degeneration has driven market revenue expansions, while innovative drug-device combinations and digital screening tools are redefining market trends. Strategic investments and collaborations in novel therapeutics, supported by ongoing market analysis and market insights, underscore an evolving landscape and set the stage for sustainable market share gains and expanding industry size. Market Size and Overview The age-related vision dysfunction market is estimated to be valued at USD 4.04 Bn in 2025 and is expected to reach USD 6.20 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.3% from 2025 to 2032. Robust pipeline assets and an ageing population are key market drivers behind this trajectory. According to the latest Age-related Vision Dysfunction Market report, investment in gene therapies and AI-based diagnostics is expanding market segments in North America and APAC. North America and APAC collectively held significant industry share in 2025, driving diverse market segments across treatments and diagnostics. This market forecast underscores robust uptake in emerging economies through 2032. ‣ Age-related Vision Dysfunction Market - https://www.coherentmi.com/industry-reports/age-related-vision-dysfunction-market